Vanda Pharmaceuticals, Inc.
9605 Medical Center Drive
Suite 300
Rockville,
MD 20850
United States - Map
Phone: 240-599-4500
Fax: 301-294-1900
Web Site: http://www.vandapharmaceuticals.com
| Vanda Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of clinical-stage drug candidates for central nervous system disorders. Its product portfolio includes Iloperidone (oral), a compound for the treatment of schizophrenia completed Phase III clinical trial; and Tasimelteon, which completed Phase III clinical trials for transient insomnia and chronic primary insomnia. The companys products also comprise Iloperidone (Injectible) for the treatment of schizophrenia and Tasimelteon for the treatment of depression, which are in the Phase II initiation status. Vanda Pharmaceuticals was founded in 2002 and is headquartered in Rockville, Maryland. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Argeris N. Karabelas Ph.D., 56
Co-Founder, Chairman, Chairman of Compensation Committee and Member of Nominating & Corp. Governance Committee |
$
65.00K | N/A | Dr. Mihael H. Polymeropoulos M.D., 49
Founder, Chief Exec. Officer, Pres |
$
442.00K |
$
0 | Mr. William D. Clark , 40
Chief Bus. Officer, Sr. VP and Sec. |
$
312.00K |
$
0 | Ms. Stephanie R. Irish C.P.A., 38
Acting Chief Financial Officer, Principal Accounting Officer, Treasurer and Controller |
N/A
| N/A | Dr. John Feeney III, M.D., 54
Acting Chief Medical Officer and Sr. Medical Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.40% Nasdaq 
Profile
